Clinical Trial Update: Translational and Clinical Aspects of Metabolic, Anabolic and Endothelial Dysfunction in Heart Failure [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/2 study examining metabolic, anabolic, and endothelial dysfunction in heart failure with reduced ejection fraction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Snippet

Sponsor: Lars Lund | Conditions: Heart Failure With Reduced Ejection Fraction HFrEF | Phase 1, Phase 2 | Status: COMPLETED